Very funny pictures http://xnxx.in.net/ xnxx videos  Patients taking the drug, called alirocumab, had their cholesterol reduced by an average of 47% over nearly six months, compared with a 16% decline in patients receiving ezetimibe, a drug marketed as Zetia by Merck & Co. (MRK). The study included 103 patients with moderate cardiovascular risk who weren't recommended by their physicians to take statins, the most effective and commonly used cholesterol-lowering treatments now on the market.